ANKRD7 Activators
ANKRD7 activators are chemical compounds that specifically interact with the ANKRD7 protein, a member of the ankyrin repeat domain-containing protein family. The ankyrin repeat is a 33-residue motif in proteins and is known for its versatility in protein-protein interactions, which is a fundamental aspect of cellular functions. ANKRD7 is one such protein that contains this domain and is involved in various intracellular processes due to its ability to bind to other proteins. Activators of ANKRD7 influence the function of this protein by altering its state or activity, often through direct binding or by modulating its interaction with other cellular components. The precise mechanisms by which these activators exert their influence can be diverse, ranging from conformational changes to the stabilization of the protein in a specific state that promotes its activity or interaction with other cellular entities.
The study of ANKRD7 activators revolves around understanding the molecular details of how these compounds interact with the ANKRD7 protein at the biochemical level. This includes exploring the binding kinetics, the specificity of the interaction, and the changes in the protein structure upon activator binding. The ankyrin repeat domain of ANKRD7, like others in its family, is recognized for its role in mediating protein-protein interactions, and thus the activators may affect how ANKRD7 associates with its partners. By elucidating the biological function of ANKRD7 and its interaction network within the cell, researchers aim to comprehend how activators can modulate these interactions. The focus is primarily on the biochemistry and structural biology of these interactions, including the activators' impact on the conformational dynamics of ANKRD7 and its subsequent biochemical pathway engagements.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular levels of cAMP. Elevated cAMP activates PKA, which can phosphorylate target proteins involved in the signaling pathways that ANKRD7 is part of, thereby enhancing ANKRD7 function. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
This cAMP analog is resistant to degradation and activates PKA, which then can phosphorylate proteins within the signaling networks that ANKRD7 is involved, leading to enhanced functional activity of ANKRD7. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents cAMP degradation, thereby indirectly enhancing the signaling pathways that involve PKA activation, potentially leading to increased ANKRD7 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
This compound is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins within the signaling cascades that ANKRD7 may be involved in, thereby indirectly enhancing ANKRD7 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates Protein Kinase C (PKC) which is involved in several signal transduction pathways. PKC activation can lead to phosphorylation of proteins in the same pathways as ANKRD7, indirectly enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels, which can activate calcium-dependent proteins and signaling pathways that ANKRD7 participates in, leading to an enhancement of ANKRD7's activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to inhibit several protein kinases, potentially reducing competition and allowing pathways where ANKRD7 is active to be less inhibited, thus indirectly enhancing ANKRD7 function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA phosphorylation can enhance the signaling pathways in which ANKRD7 is involved, leading to an upregulation of ANKRD7 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can lead to reduced Akt signaling. This shift in signaling dynamics can indirectly enhance the pathways that involve ANKRD7, potentially increasing its activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
This compound is a selective inhibitor of MEK1/2, which can lead to a reduction in ERK pathway activity. This alteration in signaling could shift the balance towards pathways involving ANKRD7, indirectly enhancing its activity. | ||||||